Increase in R&D expenditure and growth of the biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and Genome Editing technologies, non-labelling of gene-edited products such as Genetically Modified Organisms (GMOs), and applications in various drug discovery processes are some of the factors propelling personalized medicine forward.